Next Article in Journal
Evolving Role of Immunotherapy in Advanced Biliary Tract Cancers
Previous Article in Journal
Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study
 
 
Article

Article Versions Notes

Cancers 2022, 14(7), 1746; https://doi.org/10.3390/cancers14071746
Action Date Notes Link
article xml file uploaded 29 March 2022 15:51 CEST Original file -
article xml uploaded. 29 March 2022 15:51 CEST Update https://www.mdpi.com/2072-6694/14/7/1746/xml
article pdf uploaded. 29 March 2022 15:51 CEST Version of Record https://www.mdpi.com/2072-6694/14/7/1746/pdf
article supplementary file uploaded. 29 March 2022 15:51 CEST - https://www.mdpi.com/2072-6694/14/7/1746#supplementary
article html file updated 29 March 2022 15:53 CEST Original file -
article html file updated 2 August 2022 16:20 CEST Update https://www.mdpi.com/2072-6694/14/7/1746/html
Back to TopTop